All patients (n:48) | K-L Grade II patients (n:17) | K-L Grade III patients (n:16) | K-L Grade IV patients (n:15) | P | Differences between the groups | |
---|---|---|---|---|---|---|
Age | 65.1±6.7 | 64.3±7.2 | 65.1±6.5 | 65.8±6.5 | 0.834 | II = III = IV |
Body mass index | 31.4±4.0 | 30.0±4.1 | 31.6±2.8 | 32.6±4.6 | 0.186 | II = III = IV |
Calcifediol (ng/ml) | 13.7 (4.3–53.1) | 14.8 (4.3–42.7) | 10.2 (5.2–37.8) | 18.3 (5.2–53.1) | 0.213 | II = III = IV |
L1-4 BMD | 1.077±0.203 | 1.023±0.185 | 1.094±0.197 | 1.119±0.228 | 0.388 | II = III = IV |
L1-4 Z score | 0.60±1.53 | 0.09±1.36 | 0.79±1.50 | 0.98±1.68 | 0.222 | II = III = IV |
Femur neck BMD | 0.874±0.146 | 0.905±0.169 | 0.860±0.141 | 0.856±0.127 | 0.578 | II = III = IV |
Femur neck Z score | 0.41±1.09 | 0.58±1.30 | 0.31±1.03 | 0.31±0.93 | 0.719 | II = III = IV |
VAS-pain NDK | 7 (3–10) | 5 (3–9) | 6.5 (3–10) | 7 (4–9) | 0.034 | II = III, II < IV**, III = IV |
OST score NDK | 2 (1–4) | 2 (1–2) | 2.5 (2–3) | 3 (2–4) | 0.000 | II < III***, II < IV***, III < IV** |
Medial JSN score NDK | 3 (2–4) | 2 (2–2) | 3 (2–3) | 4 (3–4) | 0.000 | II < III***, II < IV***, III < IV*** |
SC sclerosis score NDK | 1 (0–3) | 1 (0–2) | 1.5 (1–3) | 2 (1–3) | 0.000 | II < III**, II < IV***, III < IV* |
NDKMCC | 0.5 (0–3) | 0 (0–2) | 1 (0–3) | 2 (0–3) | 0.002 | II < III*, II < IV**, III < IV* |
NDKLCC | 0 (0–3) | 0 (0–3) | 0 (0–3) | 1 (0–3) | 0.388 | II = III = IV |
NDKTC | 1 (0–6) | 0 (0–5) | 1.5 (0–3) | 3 (0–6) | 0.004 | II = III, II < IV**, III = IV |
MCTC | 2 (0–6) | 1 (0–3) | 2 (0–4) | 3 (0–6) | 0.006 | II = III, II < IV**, III < IV* |
LCTC | 1 (0–4) | 1 (0–3) | 0.5 (0–4) | 1 (0–4) | 0.683 | II = III = IV |
GTC | 3 (0–9) | 2 (0–5) | 3 (0–6) | 6 (0–9) | 0.007 | II = III, II < IV**, III < IV* |
NDKPFCC | 0 (0–2) | 0 (0–2) | 0 (0–2) | 0 (0–2) | 0.775 | II = III = IV |